Rudrapur,India-  Mission Cure, a prestigious international organization working for the welfare of patients suffering from pancreatitis (inflammation of the pancreas), has responded positively to an invitation to participate in the International Pancreatitis Conclave (IPCI 2027).

In her response, the organization’s co-founder and Chief Executive Officer (CEO), Megan Golden, said that receiving an invitation to participate in IPCI 2027 was an honor. She particularly appreciated the conference’s emphasis on Patient Voice, and stated that she would discuss the matter with her team, make a decision in line with the program, and inform the organizers soon.

Mission Cure is a U.S.-based international nonprofit organization that has been working to promote treatment, research, patient awareness, policy development, and global collaboration in the field of chronic pancreatitis. The organization’s goal is to accelerate global efforts toward effective treatment and ultimately a permanent solution for pancreatitis.

Padmashree Vaidya Balendu Prakash, the organizing secretary of IPCI 2027, said that the purpose of the conference is to bring together doctors, scientists, researchers, patient organizations, and policymakers from around the world on a common platform to create new opportunities for collaboration in the treatment and research of pancreatitis.

According to him, one of the key features of the conference will be that the participation of patients and patient organizations will be given equal importance alongside scientists and doctors. He added that the conference will include scientific dialogue between experts in modern medicine and Ayurveda, while patient experiences will also be considered an important basis for guiding research and treatment.

He further stated that IPCI 2027 has been receiving continuous positive responses from renowned scientists, doctors, and international organizations around the world, and expressed confidence that the conference will establish itself as a world-class scientific platform in the field of pancreatitis research and treatment.

What is Mission Cure?

Mission Cure is one of the world’s leading international nonprofit organizations based in the United States, dedicated to the treatment, research, and eventual permanent solution of pancreatitis (inflammation of the pancreas). It was founded in 2017 by Megan Golden, inspired by her brother’s struggle with chronic pancreatitis.

The organization aims to accelerate scientific research in the field of pancreatitis, encourage the development of new treatments, provide an international platform for patients’ voices, and strengthen collaboration among doctors, scientists, industry stakeholders, and policymakers.

Every year, the organization invests resources worth approximately USD 850,000 (around INR 7 to 7.5 crore) in research, patient awareness, education, clinical studies, and innovation-based projects. It has been playing an important role in advancing early-stage research, clinical trials, patient registries, and the development of new medicines.

Mission Cure is regarded as one of the world’s leading patient-support and research-promoting organizations in the field of pancreatitis. Its potential participation in IPCI 2027 is expected to provide new direction to patient-centered healthcare, international collaboration, and scientific research.